Physician

Albert Sm Manlapit, MD

According to 2025 Medicare claims, Albert Manlapit, MD (NPI: 1205805900) practices rheumatology in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is ALBERT SM MANLAPIT M.D. PLLC (NPI: 1659482347; TIN: 383489959) and primary practice location at 48604-9284. Manlapit is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), and Honest MSSP of Michigan LLC (ACO ID: A5616), participating under the MSSP model.

Manlapit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 187 traditional Medicare patients, billed 12,468 HCPCS/CPT codes, and received $319,338 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,122 prescription claims across 284 beneficiaries totaling $3,298,596 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 16 claims. Open Payments data shows 82 records totaling $1,441. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $855,100 to $3,298,596. In contrast, DME billing represents a smaller volume and declined steadily, from $830 to $173.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	446	6,965	$291,057
2016	406	9,310	$376,963
2017	330	10,693	$452,954
2018	281	12,444	$504,389
2019	278	12,325	$498,813
2020	206	12,661	$490,470
2021	197	9,751	$396,355
2022	180	10,895	$428,579
2023	192	10,227	$329,839
2024	187	12,468	$319,338

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	316	2,246	$855,100
2016	295	2,197	$1,294,034
2017	267	2,018	$1,354,520
2018	254	1,871	$1,562,514
2019	253	1,863	$1,639,348
2020	253	2,010	$1,991,282
2021	256	1,864	$2,149,449
2022	245	1,757	$1,973,733
2023	279	2,026	$2,816,879
2024	284	2,122	$3,298,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	30	$350
2017	N/R	28	$294
2018	N/R	23	$241
2019	N/R	47	$464
2020	N/R	25	$241
2021	N/R	19	$199
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	16	$173

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	76	119	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	563	$83
99442	Telephone medical discussion with physician, 11-20 minutes	71	141	$57
73100	X-ray of wrist, 2 views	80	82	$46
73120	X-ray of hand, 2 views	113	115	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	125	3,808	$968,950
Enbrel Mini	Etanercept	51	1,428	$366,136
Rinvoq	Upadacitinib	47	1,410	$293,426
Enbrel	Etanercept	33	1,068	$238,581
Skyrizi Pen	Risankizumab-Rzaa	11	644	$223,855

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0235	Paraffin bath unit, portable (see medical supply code a4265 for paraffin)	Y	N/R	16	$173

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	82	$1,441	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert Sm Manlapit, MD?

Tedicare shows public-source Medicare data for Albert Sm Manlapit, MD (NPI 1205805900), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert Sm Manlapit, MD have ACO affiliation data?

Albert Sm Manlapit, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), and Honest MSSP of Michigan LLC (MSSP, ACO ID A5616).

What billing organization is linked to Albert Sm Manlapit, MD?

Albert Sm Manlapit, MD is linked to ALBERT SM MANLAPIT M.D. PLLC (billing NPI 1659482347) in the available physician profile data.

Does Albert Sm Manlapit, MD have Open Payments data?

Albert Sm Manlapit, MD has 82 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.